Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Stores and Muscle Metabolism in Heart Failure
NCT02737995Phase 1Completed
- Sponsor
- NYU Langone Health
- Start
- May 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by NYU Langone Health. Primary endpoint: Biomarkers of iron stores at 60 minutes. Started May 2015; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02737995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737995.